Skip to content

CORRECT: COvid (Covid-19) Registry REChts der Isar intensive care Trial

CORRECT: COvid (Covid-19) Registry REChts der Isar intensive care Trial - CORRECT

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00021612
Enrollment
500
Registered
2020-04-30
Start date
2020-03-30
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 acute respiratory distress syndrome U07.1 J80

Interventions

Group 1: 1. Hemodynamic monitoring and comparison with comparable ARDS patients with other genesis. 2. Extracorporeal organ support (e.g. ADVOS, ECMO) 3. Assessment of prognosis by standard diagnosti

Sponsors

Klinikum rechts der Isar der TU München
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: all patients on ICU at Klinikum rechts der Isar with suspected or confirmed SARS-CoV-2 infection (recruitment beginning in March 2020)

Exclusion criteria

Exclusion criteria: Age < 18 years

Design outcomes

Primary

MeasureTime frame
1. Support of clinical research (e.g. prognostic marker, laboratory parameters hemodynamic monitoring, use and effectiveness of extracorporeal organ support, incidence and prognostic value of superinfections, radiologic data) 2. Description of epidemiologic correlations and differences. 3. Support of quality management. 4. Evaluation and monitoring of patient safety.

Secondary

MeasureTime frame
1. Economic assessment. 2. Resource management of the health care system.

Countries

Germany

Contacts

Public ContactSebastian Rasch

Klinikum rechts der Isar der TU München

sebastian.rasch@mri.tum.de0049 89 4140 9352

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 25, 2026